Filling the Analysis Gap in the Move to Continuous Processing

March 15, 2016
Jamie Clayton

Pharmaceutical Technology, Pharmaceutical Technology-03-15-2016, Volume 2016 eBook, Issue 1
Page Number: s34-s37

The author discusses issues and best approaches for solid dosage form pharmaceuticals.

More pharmaceutical companies are becoming interested in continuous processing, but they may face an “analytics gap,” because continuous will require a different approach to analytics. The author discusses issues and best approaches for solid dosage form pharmaceuticals.

from Pharmaceutical Technology’s 2016 Solid Dosage Drug Development and Manufacturing eBook.

View other articles in the